Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$55.37−0.01 (-0.02%)
Close on Nov 17, 2026Market cap $3.31BP/E –Yield –
Axogen total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Axogen's total debt was $0 at Sep 30, 2026. For fiscal 2025 it was $48.39M, up 1.9% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is $48.39M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.39M | +1.9% |
| FY2024 | Dec 31, 2024 | $47.50M | +1.9% |
| FY2023 | Dec 31, 2023 | $46.60M | +1.9% |
| FY2022 | Dec 31, 2022 | $45.71M | +2.0% |
| FY2021 | Dec 31, 2021 | $44.82M | +39.9% |
| FY2020 | Dec 31, 2020 | $32.03M | +1744.9% |
| FY2019 | Dec 31, 2019 | $1.74M | +2655.6% |
| FY2018 | Dec 31, 2018 | $63.00K | -99.7% |
| FY2017 | Dec 31, 2017 | $20.55M | +1.3% |
| FY2016 | Dec 31, 2016 | $20.29M | -17.9% |
| FY2015 | Dec 31, 2015 | $24.70M | -1.5% |
| FY2014 | Dec 31, 2014 | $25.09M | -1.1% |
| FY2013 | Dec 31, 2013 | $25.36M | +17.5% |
| FY2012 | Dec 31, 2012 | $21.58M | +346.0% |
| FY2011 | Dec 31, 2011 | $4.84M | -31.7% |
| FY2010 | Dec 31, 2010 | $7.08M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0 | -100.0% |
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | $0 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $48.39M | +1.9% |
| Q3 FY2025 | Sep 30, 2025 | $48.16M | +1.9% |
| Q2 FY2025 | Jun 30, 2025 | $47.94M | +1.9% |
| Q1 FY2025 | Mar 31, 2025 | $47.72M | +1.9% |
| Q4 FY2024 | Dec 31, 2024 | $47.50M | +1.9% |
| Q3 FY2024 | Sep 30, 2024 | $47.27M | +1.9% |
| Q2 FY2024 | Jun 30, 2024 | $47.05M | +1.9% |
| Q1 FY2024 | Mar 31, 2024 | $46.83M | +1.9% |
| Q4 FY2023 | Dec 31, 2023 | $46.60M | +1.9% |
| Q3 FY2023 | Sep 30, 2023 | $46.38M | +2.0% |
| Q2 FY2023 | Jun 30, 2023 | $46.15M | +2.0% |
| Q1 FY2023 | Mar 31, 2023 | $45.93M | +2.0% |
| Q4 FY2022 | Dec 31, 2022 | $45.71M | +2.0% |
| Q3 FY2022 | Sep 30, 2022 | $45.49M | -1.6% |
| Q2 FY2022 | Jun 30, 2022 | $45.26M | -1.8% |
| Q1 FY2022 | Mar 31, 2022 | $45.04M | +40.1% |
| Q4 FY2021 | Dec 31, 2021 | $44.82M | +39.9% |
| Q3 FY2021 | Sep 30, 2021 | $46.24M | +115.3% |
| Q2 FY2021 | Jun 30, 2021 | $46.08M | +2867.2% |
| Q1 FY2021 | Mar 31, 2021 | $32.14M | +980.7% |
| Q4 FY2020 | Dec 31, 2020 | $32.03M | +1744.9% |
| Q3 FY2020 | Sep 30, 2020 | $21.48M | +468.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.55M | -63.1% |
| Q1 FY2020 | Mar 31, 2020 | $2.97M | -35.1% |
| Q4 FY2019 | Dec 31, 2019 | $1.74M | +2655.6% |
| Q3 FY2019 | Sep 30, 2019 | $3.78M | +4982.4% |
| Q2 FY2019 | Jun 30, 2019 | $4.21M | +4899.5% |
| Q1 FY2019 | Mar 31, 2019 | $4.58M | -77.8% |
| Q4 FY2018 | Dec 31, 2018 | $63.00K | -99.7% |
| Q3 FY2018 | Sep 30, 2018 | $74.28K | -99.6% |
| Q2 FY2018 | Jun 30, 2018 | $84.27K | -99.6% |
| Q1 FY2018 | Mar 31, 2018 | $20.60M | +1.5% |
| Q4 FY2017 | Dec 31, 2017 | $20.55M | +1.3% |
| Q3 FY2017 | Sep 30, 2017 | $20.38M | – |
| Q2 FY2017 | Jun 30, 2017 | $20.34M | – |
| Q1 FY2017 | Mar 31, 2017 | $20.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.29M | – |
See a number that looks wrong?